Abstract: Provided is a digital putting diagnosis device for diagnosing putting, which is provided in a putter head of a golf putter, including: a 9-axis sensor unit for detecting position and movement of the putter head, the 9-axis sensor unit detecting rotation of the putter head in a roll direction, a pitch direction, and a yaw direction; a control unit for controlling the posture of the putter head at the time of addressing the putting and the swing path of the putter head during putting to be displayed in real time by using the detected signal of the 9-axis sensor unit according to the movement of the putter head; and a display unit for displaying the posture of the putter head and the swing path of the putter head under the control of the control unit.

Abstract: Provided is a digital putting diagnosis device for diagnosing putting, which is provided in a putter head of a golf putter, including: a 9-axis sensor unit for detecting position and movement of the putter head, the 9-axis sensor unit detecting rotation of the putter head in a roll direction, a pitch direction, and a yaw direction; a control unit for controlling the posture of the putter head at the time of addressing the putting and the swing path of the putter head during putting to be displayed in real time by using the detected signal of the 9-axis sensor unit according to the movement of the putter head; and a display unit for displaying the posture of the putter head and the swing path of the putter head under the control of the control unit.

Abstract: A biosensor (10) has a hydrogel (30) in a rigid and preferably biocompatible enclosure (20). The hydrogel (30) includes an immobilized analyte binding molecule (ABM) and an immobilized analyte. The immobilized analyte competitively binds with free analyte to the ABM, thus changing the number of crosslinks in the hydrogel (30), which changes hydrogel swelling tendency (and thus the osmotic pressure) in its confined space in proportion to the concentration of free analyte concentration. By measuring the change in hydrogel pressure with a pressure transducer (40), the biosensor (10) is able to accurately measure the concentration of the free analyte molecule without the problem of oxygen limitations and interference encountered by prior art biosensors. A battery (64) powered telemeter (60) operably engaged to the pressure transducer (40) sends a radio data signal to a receiver (66) containing an alarm system operably attached to a computer (62).

Abstract: A biosensor (10) has a hydrogel (30) in a rigid and preferably biocompatible enclosure (20). The hydrogel (30) includes an immobilized analyte binding molecule (ABM) and an immobilized analyte. The immobilized analyte competitively binds with free analyte to the ABM, thus changing the number of crosslinks in the hydrogel (30), which changes hydrogel swelling tendency (and thus the osmotic pressure) in its confined space in proportion to the concentration of free analyte concentration. By measuring the change in hydrogel pressure with a pressure transducer (40), the biosensor (10) is able to accurately measure the concentration of the free analyte molecule without the problem of oxygen limitations and interference encountered by prior art biosensors. A battery (64) powered telemeter (60) operably engaged to the pressure transducer (40) sends a radio data signal to a receiver (66) containing an alarm system operably attached to a computer (62).